Characterization, Antibiotic Susceptibility, and Clonal Analysis of Carbapenem-Resistant Klebsiella pneumoniae From Different Clinical Cases
- PMID: 39564009
- PMCID: PMC11573929
- DOI: 10.7759/cureus.71889
Characterization, Antibiotic Susceptibility, and Clonal Analysis of Carbapenem-Resistant Klebsiella pneumoniae From Different Clinical Cases
Abstract
Introduction: Carbapenem-resistant Klebsiella pneumoniae (CRKP) is recognized for its great ability to resist prescription drugs and its association with severe infections in humans.
Objectives: This study was designed to evaluate the characteristic resistance spectrum, to characterize the implicated carbapenem-resistant genes (CRGs), and to determine the extent of genetic diversity among Klebsiella pneumoniae isolates from human clinical cases in Duhok province. Methodology: The VITEK-2 system was used to investigate the phenotypic antibiotic susceptibility of 23 K. pneumoniae isolated from distinct human clinical situations, multiplex PCR was used to assign the key common carbapenem-resistant genes (IMP, OXA48-like, bla-NDM, and KPC) in phenotypically carbapenem-resistant isolates, and the Enterobacterial Repetitive Intergenic Consensus Polymerase Chain Reaction (ERIC-PCR) assay was utilized to ascertain the clonal associations among those isolates.
Results: Phenotypic resistance analysis revealed high resistance rates to various antibiotics, with all isolates exhibiting multidrug resistance (MDR). Coronavirus disease 2019 (COVID-19) patient isolates demonstrated significantly higher resistance compared to other sources. In addition, all isolates showed complete phenotypic resistance to carbapenems, PCR screening for CRGs identified blaOXA-48 as the predominant gene, present in all isolates. Genetic fingerprinting revealed diverse genotypes, with COVID-19 patient isolates exhibiting high similarity, contrasting with maximum diversity in non-COVID-19 clinical isolates.
Keywords: antimicrobial resistance; antimicrobial stewardship; carbapenem-resistant klebsiella pneumoniae; clonal analysis; public health.
Copyright © 2024, Taha et al.
Conflict of interest statement
Human subjects: All authors have confirmed that this study did not involve human participants or tissue. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Carbapenem-resistant hypermucoviscous Klebsiella pneumoniae clinical isolates from a tertiary hospital in China: Antimicrobial susceptibility, resistance phenotype, epidemiological characteristics, microbial virulence, and risk factors.Front Cell Infect Microbiol. 2022 Dec 21;12:1083009. doi: 10.3389/fcimb.2022.1083009. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36619764 Free PMC article.
-
Phenotypic and molecular detection of the bla KPC gene in clinical isolates from inpatients at hospitals in São Luis, MA, Brazil.BMC Infect Dis. 2016 Dec 7;16(1):737. doi: 10.1186/s12879-016-2072-3. BMC Infect Dis. 2016. PMID: 27927163 Free PMC article.
-
Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.Microbiol Spectr. 2022 Apr 27;10(2):e0229021. doi: 10.1128/spectrum.02290-21. Epub 2022 Mar 1. Microbiol Spectr. 2022. PMID: 35230130 Free PMC article.
-
Clinical carbapenem-resistant Klebsiella pneumoniae isolates simultaneously harboring bla NDM-1, bla OXA types and qnrS genes from the Kingdom of Bahrain: Resistance profile and genetic environment.Front Cell Infect Microbiol. 2022 Oct 11;12:1033305. doi: 10.3389/fcimb.2022.1033305. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36304935 Free PMC article.
-
Carbapenem-Resistant Klebsiella pneumoniae Infections in ICU COVID-19 Patients-A Scoping Review.J Clin Med. 2021 May 12;10(10):2067. doi: 10.3390/jcm10102067. J Clin Med. 2021. PMID: 34066031 Free PMC article.
Cited by
-
Predictive model for carbapenem-resistant Klebsiella pneumoniae bloodstream infection based on a nomogram: a retrospective study.BMC Res Notes. 2025 Jul 1;18(1):265. doi: 10.1186/s13104-025-07325-w. BMC Res Notes. 2025. PMID: 40598640 Free PMC article.
References
-
- A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients. Hu Y, Ping Y, Li L, Xu H, Yan X, Dai H. J Infect Dev Ctries. 2016;10:208–213. - PubMed
-
- The effect of silver nanoparticles on the antimicrobial activity of cloned nisin against extensively drug-resistant Acinetobacter baumannii". Ahmed MS, Abdulrahman ZF, Taha ZM. J Infect Public Health. 2024;17:102501. - PubMed
-
- Siddhardha B, Dyavaiah M, Syed A. Springer Nature; 2020. Model organisms for microbial pathogenesis, biofilm formation and antimicrobial drug discovery.
LinkOut - more resources
Full Text Sources